Biomanufacturing: Why single-use?Established in 2013, Polpharma Biologics is the biotechnology unit of the rapidly growing Polpharma Group one of the largest pharmaceutical players in the CEE region. Currently, with over 140 people, … more ➔
IP Flash: Cost pressureSmall companies and academic institutions develop their assets, in most cases, under budget constraints. Still, they have to meet the expectations of future strategic partners or investors in order to … more ➔
A potentially game-changing technologyIn December 2016, US biotech company Ionis Pharmaceuticals drug Spinraza received regulatory approval in the US. No doubt: the antisense technology behind Spinraza could be the next big thing more ➔
Early Certainty Initiative: Disincentive...The decision of the European Patent Office to examine all patent applications within 12 months can unintentionally block companies from filing for life sciences patents in Europe, says Gavin Recchia, … more ➔
A clear path ahead for the bioeconomyTheres no way around it: renewables are the future, Matti Heikkilä believes. European Biotechnology talked to the CTO of Finnish bioeconomy company MetGen about what bio-based products need to bring … more ➔
Europes shield against falsified medici...The pharmaceutical industry of the European Union is currently toiling at a veritably Herculean task. They jointly took up the fight against falsified pharmaceuticals in the legal supply chain. Forgers … more ➔
Making Brexit work for the life sciences s...Like every sector of the UK economy, life sciences has been beset with uncertainty since the country voted to leave the European Union. Last week prime minister Theresa May finally gave us some clarity … more ➔
Will the Trump effect last?The surprising election of Donald Trump as the next US President led to a spectacular comeback of biotech shares. The long-term prospects depend on Trumps healthcare strategy and the (much-desired) … more ➔
From randomised and controlled to clinical...The randomised clinical trial (RCT) is the gold standard for drug evaluation. RCTs provide the core for drug development and subsequent drug approval often in the form of rigorously designed efficacy … more ➔
And the world turnsWell, that was a weight off my chest, better out than in, as they say. After Brexit, at least the world will be pulled back into its axis with the election of Americas first woman president and … more ➔
